EFFICACY AND SAFETY OF ANIFROLUMAB IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF THE SECOND PHASE 3 RANDOMIZED CONTROLLED TRIAL

被引：0

作者：

Morand, Eric F. ^{[1
]}

Furie, Richard ^{[2
]}

Tanaka, Yoshiya ^{[3
]}

Bruce, Ian N. ^{[4
]}

Askanase, Anca D. ^{[5
]}

Richez, Christophe ^{[6
]}

Bae, Sang-Cheol ^{[7
]}

Brohawn, Mr Philip Z. ^{[8
]}

Pineda, Lilia ^{[8
]}

Berglind, Anna ^{[9
]}

Tummala, Raj ^{[8
]}

机构：

[1] Monash Univ, Melbourne, Vic, Australia

[2] Zucker Sch Med Hofstra Northwell, Great Neck, NY USA

[3] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan

[4] Univ Manchester, Manchester, Lancs, England

[5] Columbia Univ, Coll Phys & Surg, New York, NY USA

[6] CHU Bordeaux GH Pellegrin, Bordeaux, France

[7] Hanyang Univ Hosp Rheumat Dis, Seoul, South Korea

[8] AstraZeneca, Gaithersburg, MD USA

[9] AstraZeneca, Gothenburg, Sweden

来源：

INTERNAL MEDICINE JOURNAL | 2020年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

ARA-68

引用

页码：22 / 23

页数：2

共 50 条

[41] Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China
Zhang, Le
Geng, Shikai
Qian, Liping
Ye, Shuang
Wang, Xiaodong
Lu, Guohong
Ding, Yang
Li, Ting
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (05) : 1247 - 1255
[42] Efficacy of immunosorption in patients with systemic lupus erythematosus: A double blind controlled trial
Amosova, EN
Yaremenko, OB
Snezhkova, EA
Drannik, GV
[J]. TERAPEVTICHESKII ARKHIV, 1997, 69 (12): : 18 - 22
[43] Systemic Lupus Erythematosus Responder Index Assessment of Responders in EMBLEM, a Phase IIb Study in Patients with Moderate to Severe Systemic Lupus Erythematosus
Petri, Michelle
Pike, Marilyn C.
Kelley, Lexy
Kilgallen, Brian
Gordon, Caroline
[J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S539 - S539
[44] Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
Isenberg, David
Li, Yong
Wax, Stephen
Wofsy, David
Gordon, Caroline
[J]. ARTHRITIS RESEARCH & THERAPY, 2014, 16
[45] Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
David Isenberg
Yong Li
Stephen Wax
David Wofsy
Caroline Gordon
[J]. Arthritis Research & Therapy, 16
[46] EFFECTS OF ATACICEPT ON DISEASE ACTIVITY IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: APRIL-SLE RANDOMIZED TRIAL
Gordon, C.
Isenberg, D.
Li, Y.
Wax, S.
Wofsy, D.
Rossi, C. Pena
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 77 - 77
[47] SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF EPRATUZUMAB IN JAPANESE PATIENTS WITH MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A PHASE 1/2 STUDY
Yamamoto, J.
Lledo-Garcia, R.
Tsuru, T.
Tanaka, Y.
Koike, T.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 526 - 526
[48] FLARE ASSESSMENTS IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH ANIFROLUMAB IN 2 PHASE 3 TRIALS
Furie, R.
Morand, E. F.
Askanase, A.
Vital, E.
Kalyani, R.
Abreu, G.
Pineda, L.
Tummala, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1024 - 1025
[49] EFFICACY AND SAFETY OF RITUXIMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Ren, Y.
Wang, L.
An, Z.
Yang, L.
Su, Q. Y.
Yu, Q.
He, P. F.
Li, X.
Zhang, S. X.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1477 - 1477
[50] Efficacy and Safety of Cenerimod in Patients with Moderate to Severe Systemic Lupus Erythematosus (SLE): A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2b Trial
Askanase, Anca
Berkani, Ouali
Cahuzac, Clelia
Cornelisse, Peter
D'Cruz, David
Kalunian, Kenneth
Merrill, Joan
Pozzobon, Marilia
Navarra, Sandra
[J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3293 - 3297

← 1 2 3 4 5 →